The role of mass spectrometry in biomarker discovery and measurement.
about
Fine mapping the spatial distribution and concentration of unlabeled drugs within tissue micro-compartments using imaging mass spectrometry.Detection of co-eluted peptides using database search methods.MRM screening/biomarker discovery with linear ion trap MS: a library of human cancer-specific peptidesLiquid chromatography-mass spectrometry: a tool for proteome analysis and biomarker discovery and validation.Novel three-dimensional MALDI plate for interfacing high-capacity LC separations with MALDI-TOF.A new data mining approach for profiling and categorizing kinetic patterns of metabolic biomarkers after myocardial injury.MALDI-TOF MS profiling as the first-tier screen for sickle cell disease in neonates: matching throughput to objectives.Selective enrichment and sensitive detection of peptide and protein biomarkers in human serum using polymeric reverse micelles and MALDI-MSMatrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology.Impact of drug administration route on drug delivery and distribution into the lung: an imaging mass spectrometry approach.A case report - Volatile metabolomic signature of malignant melanoma using matching skin as a control.Quantitative proteomics for identifying biomarkers for tuberculous meningitis.Coupling immunoaffinity techniques with MS for quantitative analysis of low-abundance protein biomarkers.Biomarkers in translational research: focus on discovery, development and translation of protein biomarkers to clinical immunoassays.Target validation to biomarker development: focus on RNA interference.Comparative analysis of volatile metabolomics signals from melanoma and benign skin: a pilot study.Microarray methods for protein biomarker detectionApplication of metabonomic analytical techniques in the modernization and toxicology research of traditional Chinese medicineSurrogate end points: how well do they represent patient-relevant end points?Bioinformatic-driven search for metabolic biomarkers in diseaseHigh-field asymmetric waveform ion mobility spectrometry with solvent vapor addition: a potential greener bioanalytical technique.NMR and MS Methods for Metabolomics.Diagnostics and Resistance Profiling of Bacterial Pathogens.Unbiased Metabolomic Investigation of Alzheimer's Disease Brain Points to Dysregulation of Mitochondrial Aspartate Metabolism.PTMScan direct: identification and quantification of peptides from critical signaling proteins by immunoaffinity enrichment coupled with LC-MS/MS.9G DNAChip Technology: Self-Assembled Monolayer (SAM) of ssDNA for Ultra-Sensitive Detection of Biomarkers.Hierarchical cluster analysis of technical replicates to identify interferents in untargeted mass spectrometry metabolomics.Nanoparticle technology: Addressing the fundamental roadblocks to protein biomarker discovery.
P2860
Q28474824-A689FAD6-2899-4FCB-96F1-AFFAEE4AC94BQ33348774-28104F3B-8C8C-4E19-AA49-CD2215D4ADD3Q33423243-F7831655-2D49-456C-B2C3-72F76146E313Q33457379-E6664A98-8D1B-49E8-8212-8F11B635E430Q33474040-2A710D98-71CB-49B7-8FA2-EA639A933329Q33581735-873A6A0F-D99A-4033-81B2-2F3823A11245Q33959640-9AECF343-DA83-4A7E-ACED-8B6DFDD19798Q34109421-72383CE1-A86C-42BF-94E3-298D0058547AQ34653849-AE1189C1-0E06-435A-ABC7-D4FF9111A3D3Q35078907-2B87A6E7-276E-45A6-B76C-EE2FD439E787Q35651462-49807FC2-5B67-43E1-9EB7-C82B2EF8CFBCQ36609936-B80ABB9D-5F97-44B4-83D7-68C8E7E77E61Q36787221-6D5AD112-F472-4393-8F54-3E0203A253E2Q36950431-DDB7C24E-70FF-48FA-9F16-002A97B8328DQ37141990-7206F5AF-9CE2-431C-B89F-5F80647B0EC3Q37161693-BC7CE477-4B5D-4686-AFE5-9E7674EA53DFQ37335033-16C4823B-1790-4E19-8713-EC3E36DF24C5Q37346519-F409BB83-911F-4B74-B5D7-E8983E94940EQ37755085-37781A42-22B0-4C7E-B3F1-D8808A0F6088Q37925151-3D9FFDEC-7F47-4A3A-9CB9-5F0704ACF1BCQ38020526-9959254D-4EDC-4244-B539-66C6C4387247Q38658442-D6F559F2-6E99-40DE-88F5-9AC8D87CBA57Q38836258-CC1BC3DA-70A9-47EA-B281-07C831C46E69Q38926696-4CC8CC8D-774A-4316-9287-053DAB79DD9EQ39398876-34F5518B-3D58-468B-A80C-D5AFC2DD6F02Q40045582-2B66BE77-2C7A-4A01-8A4F-CFEDA8F59BB5Q52313333-99AED023-0514-4F43-9B4F-3427CCED7C9CQ55518386-6F9F09C6-AD89-4D96-93B8-22BB25DDF932
P2860
The role of mass spectrometry in biomarker discovery and measurement.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
The role of mass spectrometry in biomarker discovery and measurement.
@ast
The role of mass spectrometry in biomarker discovery and measurement.
@en
type
label
The role of mass spectrometry in biomarker discovery and measurement.
@ast
The role of mass spectrometry in biomarker discovery and measurement.
@en
prefLabel
The role of mass spectrometry in biomarker discovery and measurement.
@ast
The role of mass spectrometry in biomarker discovery and measurement.
@en
P2093
P1476
The role of mass spectrometry in biomarker discovery and measurement.
@en
P2093
Bradley L Ackermann
John E Hale
Kevin L Duffin
P304
P356
10.2174/138920006777697918
P407
P577
2006-06-01T00:00:00Z